Stocks Actavis Inc

More

  • *Pfizer set to buy Allergan for $160 bln. Copper fell to its cheapest in six months before recovering, while London nickel slid to its lowest since 2003. Gold fell nearly one percent towards last week's near-six-year low. "In the context of a market waiting for supply-side cuts, a stronger dollar is only going to weigh on the cost curve and constrain the pace at which...

  • Nov 23- Pfizer Inc's looming deal to buy Botox maker Allergan Plc for more than $150 billion will cap a record-breaking run for mergers and acquisitions in the healthcare sector, taking the cumulative value of deals in 2015 to more than $600 billion. Pfizer's tax-driven takeover of Allergan, which people familiar with the matter said won board approval on...

  • WASHINGTON, Nov 23- The White House declined to comment on Pfizer's acquisition of Allergan, the biggest-ever tax inversion deal, but said Congress should take legislative action to prevent deals where companies lower their taxes by reincorporating overseas.

  • Democratic presidential candidate Hillary Clinton on Monday bashed Pfizer Inc's deal to buy Allergan PLC, saying she would propose steps to prevent tax inversions and calling on regulators to take tougher action.

  • *Pfizer, Allergan drop after biggest-ever healthcare deal. Pfizer's shares were down 2.1 percent at $31.51, after the company said it would buy fellow drugmaker Allergan in a deal valued at about $160 billion, the biggest ever in the healthcare sector. Allergan fell 2.4 percent to $305.11.

  • *Allergan, Pfizer drop after biggest-ever healthcare deal. Pfizer's shares fell 3 percent to $31.20, after the company said it would buy Allergan in a deal valued at about $160 billion, the biggest ever in the healthcare sector. The two stocks were the biggest drags on the S&P 500, while Pfizer was the biggest drag on the Dow.

  • *Pfizer set to buy Allergan for $160 bln. Stocks in major markets ticked lower after five days of gains and the euro fell as low as $1.0599, a seven-month low as the prospect of more policy easing by the European Central Bank was compounded by a security lockdown in Brussels. The healthcare sector was also in focus after Pfizer said it would buy Botox maker Allergan...

  • *Allergan, Pfizer drop after biggest-ever healthcare deal. *Alcoa up on report of Elliott stake, boosts materials. Pfizer's shares fell 2 percent to $31.54, after the company said it would buy Allergan in a deal valued at about $160 billion, the biggest ever in the healthcare sector.

  • *Allergan, Pfizer drop after biggest ever healthcare deal. *Mallinckrodt up after posting higher sales. Nov 23- U.S. stock indexes were set to open little changed on Monday, coming off last week's strong gains, as investors head into Thanksgiving week.

  • UPDATE 2-Pfizer to buy Allergan in $160 billion deal Monday, 23 Nov 2015 | 8:59 AM ET

    Nov 23- Pfizer Inc on Monday said it would buy Botox maker Allergan Plc in a record-breaking deal worth $160 billion, designed to cut the company's U.S. tax bill by moving its headquarters to Ireland. Investors had been hoping Pfizer would sell off its low-margin generics by 2017 while holding on to its faster-growing branded prescription drugs, a move that will...

  • GLOBAL MARKETS-Commodities hit as dollar rises Monday, 23 Nov 2015 | 8:18 AM ET

    *Pfizer set to buy Allergan for over $150 bln- sources. Industrial metals copper and nickel plunged and oil prices whipsawed, while the euro fell as low as $1.06 as the prospect of more policy easing by the ECB in Europe was compounded by a security lockdown in Brussels. Oil prices were highly volatile, with U.S. crude off $1.30 or 3 percent at $40.60 a barrel at one...

  • *Geopolitical security issues also weighed on investors' minds with a lockdown in Brussels continuing for a third day as police hunt for a suspected Islamist militant on the run since the Nov. 13 attacks in Paris. *Allergan's shares were down 2.4 percent at $305 in premarket trading, after agreeing to be bought by Pfizer in a deal valued at about $160 billion.

  • Pfizer Chief Executive Ian Read will be CEO of the combined company, while Allergan CEO Brent Saunders will be Chief Operating Officer, the companies said on Monday. New York- based Pfizer and Allergan, headquartered in Ireland, said Allergan shareholders will receive 11.3 shares in the combined company for each share held. Pfizer stockholders will have the...

  • New York- based Pfizer and Allergan, headquartered in Ireland, said on Monday that Pfizer would offer 11.3 of its own shares for each Allergan share. Pfizer stockholders will receive one share of the combined company for each of their Pfizer shares. Pfizer Chief Executive Ian Read will be CEO of the combined company, while Allergan CEO Brent Saunders will be Chief...

  • *Pfizer set to buy Allergan for over $150 bln- sources. Oil fell more than 3 percent and industrial metals copper and nickel plunged, while the euro sagged to a seven-month low as the prospect of more policy easing by the ECB in Europe was compounded by a security lockdown in Brussels. Copper slumped to a fresh six-and-a-half year low and nickel tumbled 4 percent to...

  • Nov 23- Pfizer Inc's looming deal to buy Botox maker Allergan Plc for more than $150 billion will cap a record-breaking run for mergers and acquisitions in the healthcare sector, taking the cumulative value of deals in 2015 to more than $600 billion. Pfizer's tax-driven takeover of Allergan, which people familiar with the matter said won board approval on...

  • *Pfizer set to buy Allergan for over $150 bln- sources. SYDNEY, Nov 23- The euro sagged to a seven-month trough on Monday as the prospect of more policy easing in Europe benefited the U.S. dollar, while activity in Asian shares was crimped by a holiday in Japan. The head of the European Central Bank, Mario Draghi, last week offered the strongest hint yet that the ECB will...

  • *Pfizer set to buy Allergan for over $150 bln- sources. MSCI's broadest index of Asia-Pacific shares outside Japan was all but flat, while South Korea's main index gained 0.2 percent. Sources told Reuters that Pfizer Inc was due to secure formal board approval for its acquisition of Allergan Plc for more than $150 billion, creating the world's biggest drug maker.

  • Nov 22- Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc for more than $150 billion, making it the healthcare sector's largest deal ever, according to people familiar with the matter. The agreement is set to draw political ire in a U.S. presidential election year for Pfizer's decision to use the...

  • Nov 22- Pfizer Inc's and Allergan Plc's boards of directors were due to approve their merger agreement on Sunday, in the healthcare sector's largest ever deal, according to people familiar with the matter. The deal, valued at more than $150 billion, would involve Pfizer paying with 11.3 of its shares for each Allergan share, the people said. While the transaction...